This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
The NSF will support a UAB/BBA collaboration through a $600,000 award — the first Partnership for Innovation grant ever given in Alabama.
Back to Top